AAAAAA
Results: 1-25/31
Authors:
SANDLER A
DENHAM C
VONPAWEL J
CORMIER Y
GATZEMEIER U
MATTSON K
MANEGOLD C
GREGOR A
BLATTER J
EINHORN L
Citation: A. Sandler et al., SIGNIFICANTLY HIGHER SURVIVAL WITH GEMCITABINE-CISPLATIN VS CISPLATININ ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - FINAL RESULTS FROM ANINTERNATIONAL RANDOMIZED PHASE-III STUDY, Annals of oncology, 9, 1998, pp. 409-409
Authors:
GATZEMEIER U
BILDAT S
HARSTRICK A
EBERHARDT W
ACHTERRATH W
KRAUSS C
WILKE HJ
Citation: U. Gatzemeier et al., PHASE-I STUDY OF DOCETAXEL IN COMBINATION WITH GEMCITABINE AS FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC NONSMALL CELL LUNG-CANCER(NSCLC), Annals of oncology, 9, 1998, pp. 448-448
Authors:
STEWARD WP
VONPAWEL J
GATZEMEIER U
WOLL P
THATCHER N
KOSCHEL G
CLANCY L
VERWEIJ J
DEWIT R
PFEIFER W
FENNELLY J
VONEIFF M
FRISCH J
Citation: Wp. Steward et al., EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS, Journal of clinical oncology, 16(2), 1998, pp. 642-650
Authors:
VONPAWEL J
GATZEMEIER U
MEHL B
EDLER L
BAUMGART J
DRINGS P
Citation: J. Vonpawel et al., CLINICAL-PHASE-II TRIAL OF TREOSULFAN IN PATIENTS WITH NONRESECTABLE NON-SMALL-CELL LUNG-CANCER, Onkologie, 21(4), 1998, pp. 316-319
Authors:
GIACCONE G
MANEGOLD C
ROSELL R
GATZEMEIER U
QUOIX E
Citation: G. Giaccone et al., AN UPDATE ON EUROPEAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 11-17
Authors:
GATZEMEIER U
MANEGOLD C
EBERHARD W
WILKE HJ
CHOMY F
CHOMY P
KHAYAT D
BLATTER J
SEEBER S
DRINGS P
Citation: U. Gatzemeier et al., IFOSFAMIDE AND GEMCITABINE - A PHASE-II TRIAL IN ADVANCED INOPERABLE NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 15-18
Authors:
GATZEMEIER U
RODRIGUEZ G
TREAT J
MILLER V
VONROEMELING R
VIALLET J
REY A
Citation: U. Gatzemeier et al., TIRAPAZAMINE-CISPLATIN - THE SYNERGY, British Journal of Cancer, 77, 1998, pp. 15-17
Authors:
GATZEMEIER U
THOMAS P
CARDENAL F
SNIJDER RJ
SAMARAS N
MELO MJ
AUMANN J
HERMANN R
PUGANIGG K
BADRI N
Citation: U. Gatzemeier et al., PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-III TRIAL OF AN ESTABLISHEDCHEMOTHERAPY (CT) REGIMEN WITH OR WITHOUT LENOGRASTIM (RHUG-CSF) IN SMALL-CELL LUNG-CANCER (SCLC) - IMPACT ON SURVIVAL, European journal of cancer, 33, 1997, pp. 1033-1033
Authors:
VONPAWEL J
DEPIERRE A
HANS K
MORO D
CLARK P
GATZEMEIER U
PAILLOT N
SCHEITHAUER W
CARMICHAEL J
SANTORO A
ROSS G
MARANGOLO M
Citation: J. Vonpawel et al., TOPOTECAN (HYCAMTIN(TM)) IN SMALL-CELL LUNG-CANCER (SCLC) AFTER FAILURE OF FIRST LINE THERAPY - MULTICENTER PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 1038-1038
Authors:
VONPAWEL J
GATZEMEIER U
VANSTEENKISTE J
WEYNANTS P
HANAUSKE A
BOSQUEE L
MANSOURI K
ZNAMENSKY S
BLATTER J
MANEGOLD C
Citation: J. Vonpawel et al., GEMCITABINE AND ETOPOSIDE IN CHEMONAIVE PATIENTS WITH EXTENSIVE SMALL-CELL LUNG-CANCER (SCLC) - PRELIMINARY PHASE-II RESULTS, European journal of cancer, 33, 1997, pp. 1054-1054
Authors:
GATZEMEIER U
VONPAWEL J
TISCHERNEUHAUS R
HAUS U
FARBER L
Citation: U. Gatzemeier et al., TREATMENT INTENSIFICATION WITH INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1095-1095
Authors:
GATZEMEIER U
JAGOS U
KAUKEL E
KOSCHEL G
VONPAWEL J
Citation: U. Gatzemeier et al., PACLITAXEL, CARBOPLATIN, AND ORAL ETOPOSIDE - A PHASE-II TRIAL IN LIMITED-STAGE SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 149-152
Authors:
GATZEMEIER U
MANEGOLD C
EBERHARD W
WILKE HJ
CHOMY F
CHOMY P
KHAYAT D
BLATTER J
SEEBER S
DRINGS P
Citation: U. Gatzemeier et al., A PHASE-II TRIAL OF GEMCITABINE AND IFOSFAMIDE IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 836-838
Authors:
SHEPHERD FA
ABRATT RP
ANDERSON H
GATZEMEIER U
ANGLIN G
IGLESIAS J
Citation: Fa. Shepherd et al., GEMCITABINE IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 24(2), 1997, pp. 50-55
Authors:
RASSMANN I
THODTMANN R
DEPENBROCK H
BLATTER J
GATZEMEIER U
RASTETTER J
HANAUSKE AR
Citation: I. Rassmann et al., GEMCITABINE AND ETOPOSIDE IN SMALL-CELL LUNG-CANCER - PHASE-I AND PHASE-II TRIALS, Seminars in oncology, 24(2), 1997, pp. 75-78
Authors:
LECHEVALIER T
GOTTFRIED M
GATZEMEIER U
SHEPHERD F
WEYNANTS P
COTTIER B
GROEN HJM
ROSSO R
MATTSON K
CORTESFUNES H
TONATO M
BURKES RL
VOI M
PONZIO A
Citation: T. Lechevalier et al., A PHASE-II STUDY OF GEMCITABINE IN THE TR EATMENT OF NON-SMALL-CELL LUNG-CANCER, Bulletin du cancer, 84(3), 1997, pp. 282-288
Authors:
GATZEMEIER U
SHEPHERD FA
LECHEVALIER T
WEYNANTS P
COTTIER B
GROEN HJM
ROSSO R
MATTSON K
CORTESFUNES H
TONATO M
BURKES RL
GOTTFRIED M
VOI M
Citation: U. Gatzemeier et al., ACTIVITY OF GEMCITABINE IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER -A MULTICENTER, EXTENDED PHASE-II STUDY, European journal of cancer, 32A(2), 1996, pp. 243-248
Authors:
GATZEMEIER U
Citation: U. Gatzemeier, TAXOL IN BRONCHIOGENIC CARCINOMA, Medizinische Klinik, 91, 1996, pp. 1-6
Authors:
FIEBIG HH
HENSS H
VONPAWEL L
GATZEMEIER U
MANEGOLD C
EDLER L
BERDEL W
Citation: Hh. Fiebig et al., PHASE-II CLINICAL-TRIAL OF LOBAPLATIN (D-19466) IN PRETREATED PATIENTS WITH SMALL-CELL LUNG-CANCER, Onkologie, 19(4), 1996, pp. 328-332
Authors:
MANEGOLD C
DRINGS P
GATZEMEIER U
VONPAWEL J
FIEBIG HH
QUEISSER W
EDLER L
Citation: C. Manegold et al., LOBAPLATIN (D-19466) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - A TRIAL OF THE ASSOCIATION-FOR-MEDICAL-ONCOLOGY (AIO) PHASE-II STUDY-GROUP, Onkologie, 19(3), 1996, pp. 248-251
Authors:
BOHUSLAVIZKI KH
BRENNER W
GUNTHER M
EBERHARDT JU
JAHN N
TINNEMEYER S
WOLF H
SIPPEL C
CLAUSEN M
GATZEMEIER U
HENZE E
Citation: Kh. Bohuslavizki et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN THE STAGING OF SMALL-CELL LUNG-CANCER, Nuclear medicine communications, 17(3), 1996, pp. 191-196
Authors:
GATZEMEIER U
NEUHAUSS R
SCHLUTER I
VONPAWEL J
WAGNER H
DIERGARTEN K
Citation: U. Gatzemeier et al., SINGLE-AGENT PACLITAXEL AS A 3-HOUR INFUSION, Seminars in oncology, 23(6), 1996, pp. 94-97
Authors:
STEWARD WP
VONPAWEL J
GATZEMEIER U
THATCHER N
FRISCH J
Citation: Wp. Steward et al., DOSE-INTENSIFICATION OF V-ICE CHEMOTHERAPY WITH GM-CSF IN SMALL-CELL LUNG-CANCER (SCLC) - A PROSPECTIVE RANDOMIZED STUDY OF 301 PATIENTS, European journal of cancer, 31A, 1995, pp. 80-80
Authors:
TRILLETLENOIR V
GREEN JA
MANEGOLD C
VONPAWEL J
GATZEMEIER U
LEBEAU B
DEPIERRE A
JOHNSON P
DECOSTER G
MATCHAM J
EWEN C
Citation: V. Trilletlenoir et al., RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR IN THE TREATMENT OFSMALL-CELL LUNG-CANCER - A LONG-TERM FOLLOW-UP, European journal of cancer, 31A(12), 1995, pp. 2115-2116
Authors:
DUBOIS A
VACH W
CRAMERGIRAUD U
THOMSSEN C
GLAUBITZ M
FIOLA M
AUGENER W
BARTSCH W
BERGMANN F
BIERBAUM W
KRAPP J
BONING L
BONGARTZ U
BRUNTSCH U
VONBULTZINGSLOWEN F
DIETL J
FUGER T
FULLE HH
GATZEMEIER U
GROPP C
HARTLAPP H
HERSCHLEIN HJ
HOLTKAMP W
HURST U
JANICKE F
KAUKEL E
KLEEBERG U
ENGEL E
KRAFFT W
KUHNLE H
LINDEMANN H
MARSCHNER N
MEERPOHL HG
NIEDERLE N
OSIEKA R
PLANKER M
RIESS H
SCHMIDT M
SCHMOLL HJ
SCHUNEMANN H
WEINGARTJESSE B
WEITZEL H
WESTERHAUSEN M
WINKELMANN M
Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651